Analysis of patients (pts) without an initial triple-negative breast cancer (TNBC) diagnosis (Dx) in the phase III ASCENT study of sacituzumab govitecan (SG) in brain metastases-negative (BMNeg) metastatic TNBC (mTNBC) Meeting Abstract
| Authors: | O'Shaughnessy, J.; Brufsky, A.; Rugo, H. S.; Tolaney, S. M.; Diab, S.; Punie, K.; Sardesai, S.; Hamilton, E.; Loirat, D.; Traina, T. A.; Leon-Ferre, R.; Hurvitz, S. A.; Kalinsky, K.; Bardia, A.; Henry, S.; Mayer, I.; Hong, Q.; Phan, S.; Cortes, J. |
| Abstract Title: | Analysis of patients (pts) without an initial triple-negative breast cancer (TNBC) diagnosis (Dx) in the phase III ASCENT study of sacituzumab govitecan (SG) in brain metastases-negative (BMNeg) metastatic TNBC (mTNBC) |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S473 |
| End Page: | S474 |
| Language: | English |
| ACCESSION: | WOS:000700527700237 |
| DOI: | 10.1016/j.annonc.2021.08.541 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 258P -- Source: Wos |
